ClinicalTrials.Veeva

Menu

Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066

Novartis logo

Novartis

Status and phase

Completed
Phase 2

Conditions

Obesity

Treatments

Dietary Supplement: Carbohydrate 0%
Dietary Supplement: Carbohydrate 8%
Dietary Supplement: Carbohydrate 50%
Dietary Supplement: Psyllium
Drug: LIK066
Dietary Supplement: Calcium carbonate
Dietary Supplement: Carbohydrate 25%

Study type

Interventional

Funder types

Industry

Identifiers

NCT03198767
CLIK066B2203

Details and patient eligibility

About

The purpose of this study was to determine if LIK066 taken with a meal containing low carbohydrate is associated with less diarrhea compared to a high carbohydrate meal and to assess the potential effects of supplements such as psyllium or calcium carbonate on alleviating diarrhea associated with LIK066.

Enrollment

54 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • obese and overweight, BMI 25-50, HbA1C <10%

Exclusion criteria

  • Preexisting, clinically significant cardiovascular, liver, renal, or GI disease that is considered unstable; pregnancy, Type 1 diabetes; Other protocol-defined inclusion/exclusion criteria may apply

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

54 participants in 7 patient groups

Part A: LIK066 + P1: 50% CHO / P2: 25% CHO / P3: 0% CHO
Experimental group
Description:
Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 50% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 25% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 0% carbohydrate
Treatment:
Dietary Supplement: Carbohydrate 50%
Dietary Supplement: Carbohydrate 25%
Drug: LIK066
Dietary Supplement: Carbohydrate 0%
Part A: LIK066 + P1: 25% CHO / P2: 0% CHO / P3: 50% CHO
Experimental group
Description:
Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 25% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 0% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 50% carbohydrate
Treatment:
Dietary Supplement: Carbohydrate 50%
Dietary Supplement: Carbohydrate 25%
Drug: LIK066
Dietary Supplement: Carbohydrate 0%
Part A: LIK066 + P1: 0% CHO / P2: 50% CHO / P3: 25% CHO
Experimental group
Description:
Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 0% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 50% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 25% carbohydrate
Treatment:
Dietary Supplement: Carbohydrate 50%
Dietary Supplement: Carbohydrate 25%
Drug: LIK066
Dietary Supplement: Carbohydrate 0%
Part A: LIK066 + P1: 8% CHO
Experimental group
Description:
Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 8% carbohydrate (CHO) PROTOCOL DEVIATION: subjects received 8% CHO in error and were discontinued after Period 1.
Treatment:
Dietary Supplement: Carbohydrate 8%
Drug: LIK066
Part B: LIK066 + 50% CHO + P1: NS / P2: PS / P3: CC
Experimental group
Description:
Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC)
Treatment:
Dietary Supplement: Calcium carbonate
Dietary Supplement: Carbohydrate 50%
Drug: LIK066
Dietary Supplement: Psyllium
Part B: LIK066 + 50% CHO + P1: PS / P2: CC / P3: NS
Experimental group
Description:
Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS)
Treatment:
Dietary Supplement: Calcium carbonate
Dietary Supplement: Carbohydrate 50%
Drug: LIK066
Dietary Supplement: Psyllium
Part B: LIK066 + 50% CHO + P1: CC / P2: NS / P3: PS
Experimental group
Description:
Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS)
Treatment:
Dietary Supplement: Calcium carbonate
Dietary Supplement: Carbohydrate 50%
Drug: LIK066
Dietary Supplement: Psyllium

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems